The present review is an update of the research and development efforts regarding the use
of molecular biomarkers in the lung cancer screening setting. The two main unmet clinical …

In Europe, lung cancer ranks third among the most common cancers, remaining the biggest
killer. Since the publication of the first European Society of Radiology and European …

Importance Lung cancer is the second most common cancer and the leading cause of
cancer death in the US. In 2020, an estimated 228 820 persons were diagnosed with lung …

肺癌是中国发病率和死亡率最高的恶性肿瘤. 筛查与早诊早治是降低人群肺癌死亡率的有效措施
. 制定符合中国国情的肺癌筛查与早诊早治指南, 将极大推进中国肺癌筛查的同质性和优质性 …

Background: There are well-documented disparities in lung cancer outcomes across
populations. Lung cancer screening (LCS) has the potential to reduce lung cancer mortality …

Background The risks from potential exposure to coronavirus disease 2019 (COVID-19), and
resource reallocation that has occurred to combat the pandemic, have altered the balance of …

Lung cancer remains the leading cause of cancer mortality in the United States. Lung cancer
screening (LCS) with low-dose CT reduces mortality among high-risk current and former …

Importance The US Preventive Services Task Force recommends that shared decision
making (SDM) involving a thorough discussion of benefits and harms should occur between …

Lung cancer is the leading cause of cancer-related deaths worldwide, accounting for almost
a fifth of all cancer-related deaths. Annual computed tomographic lung cancer screening …

Introduction For never-smokers (smoked< 100 lifetime cigarettes), lung cancer (LC) has
emerged as an important issue. We aimed to investigate the effects of prevalence changes …